
81 - 100 of 7862


74 Sunshine Health Foundation IQ Appeal Alfredsson et al.
74 Sunshine Health Foundation IQ Appeal Alfredsson et al.

74 Sunshine Health Foundation IQ Appeal Hoel et al.
74 Sunshine Health Foundation IQ Appeal Hoel et al.

74 CDC Interim Response to Sunshine Health Foundation
74 CDC Interim Response to Sunshine Health Foundation




71 RFC Sunshine Health Foundation Appeal - Melanoma Prevention and Screening
71 RFC Sunshine Health Foundation Appeal - Melanoma Prevention and Screening


71 CDC Interim Response to Sunshine Health Foundation
71 CDC Interim Response to Sunshine Health Foundation

75 CDC Interim Response: Lawyers’ Committee for Civil Rights Under Law 10-26-2020
75 CDC Interim Response: Lawyers’ Committee for Civil Rights Under Law 10-26-2020


Maximizing Data Interoperability and Integration to Support Value-Based Care
Stakeholders broadly recognize the imperative of accessing, exchanging, integrating and using data from across the care spectrum to achieve the goals of value-based care.
Maximizing Data Interoperability and Integration to Support Value-Based Care


HHS Initiative to Improve Maternal Health
The Action Plan summarizes the Department’s work to ensure the U.S. is one of the safest countries in the world to give birth, the Surgeon General’s Call to Action outlines strategies and actions for a diverse set of external stakeholders to improve maternal health.


How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing? Issue Brief
How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing? Issue Brief
Robin Ghertner and Mir M. Ali
U.S. Department of Health and Human Services
Office of the Assistant Secretary for Planning and Evaluation
December 2020
Link to Printer Friendly Version in PDF Format (8 PDF pages)


Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief
Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief
Mir M. Ali, Kristina West, and Emma Nye
U.S. Department of Health and Human Services
Office of the Assistant Secretary for Planning and Evaluation
December 2


How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing? Issue Brief
How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing? Issue Brief
Robin Ghertner and Mir M. Ali
U.S. Department of Health and Human Services
Office of the Assistant Secretary for Planning and Evaluation
December 2020
Link to HTML Version (8 PDF pages)
DATAWaiverIB.pdf


Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief
Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief
Mir M. Ali, Kristina West, and Emma Nye
U.S. Department of Health and Human Services
Office of the Assistant Secretary for Planning and Evaluation
December 2
PostpartOUDIB.pdf


Administering Work-Related Requirements Across Human Services Programs: Service Delivery Approaches
This brief discusses two primary approaches for providing employment-related services to Temporary Assistance for Needy Families (TANF), Supplemental Nutrition Assistance Program (SNAP), and public housing program participants to help them meet work-related requirements. The findings are based on discussions with state and local administrators and
Administering Work-Related Requirements Across Human Services Programs


Medicare Part B Drugs: Trends in Spending and Utilization, 2006-2017
Medicare covers prescription drugs provided during inpatient hospital and skilled nursing facility stays through Part A, retail prescription drugs through Part D, and drugs provided in physicians’ offices and hospital outpatient departments through Part B.
Medicare Part B Drug Spending and Utilization


Medicare FFS Part B and International Drug Prices: A Comparison of the Top 50 Drugs
The September 13, 2020 Executive Order on Lowering Drug Prices by Putting America First declared, “It is the policy of the United States that the Medicare program should not pay more for costly Part B or Part D prescription drugs or biological products than the most-favored-nation price.”
Medicare FFS Part B and International Drug Prices